1. Home
  2. VYGR vs CTW Comparison

VYGR vs CTW Comparison

Compare VYGR & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.62

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

Logo CTW Cayman Class A Ordinary Shares

CTW

CTW Cayman Class A Ordinary Shares

N/A

Current Price

$1.30

Market Cap

171.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
CTW
Founded
2013
2013
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
193.5M
171.0M
IPO Year
2015
2025

Fundamental Metrics

Financial Performance
Metric
VYGR
CTW
Price
$1.62
$1.30
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $14.22
N/A
AVG Volume (30 Days)
★ 945.7K
11.8K
Earning Date
11-05-2026
10-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $10,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$172.11
N/A
P/E Ratio
★ N/A
$22.41
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$1.10
52 Week High
$5.19
$3.10

Technical Indicators

Market Signals
Indicator
VYGR
CTW
Relative Strength Index (RSI) 36.85 28.13
Support Level N/A $1.19
Resistance Level $2.04 $3.02
Average True Range (ATR) 0.15 0.18
MACD 0.01 -0.02
Stochastic Oscillator 16.22 0.00

Price Performance

Historical Comparison
VYGR
CTW

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About CTW CTW Cayman Class A Ordinary Shares

CTW operates as a gaming platform company providing instant access to free-to-play, browser-based games inspired by popular Japanese animation, including "So I'm a Spider, So What? Ruler of the Labyrinth, Arifureta: From Commonplace to World's Strongest - Rebellion Soul", and "Queen's Blade Limit Break". CTW delivers these games through its flagship HTML5 platform, G123.jp.

Share on Social Networks: